Coxsackievirus A7 and Enterovirus A71 Significantly Reduce SARS-CoV-2 Infection in Cell and Animal Models
Viruses · 2024
DOI: 10.3390/v16060909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Victor A Svyatchenko und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Disease Models, Animal, Virus Replication. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
In this study, we investigated the features of co-infection with SARS-CoV-2 and the enterovirus vaccine strain LEV8 of coxsackievirus A7 or enterovirus A71 for Vero E6 cells and Syrian hamsters. The investigation of co-infection with SARS-CoV-2 and LEV-8 or EV-A71 in the cell model showed that a competitive inhibitory effect for these viruses was especially significant against SARS-CoV-2. Pre-infection with enteroviruses in the animals caused more than a 100-fold decrease in the levels of SARS-CoV-2 virus replication in the respiratory tract and more rapid clearance of infectious SARS-CoV-2 from the lower respiratory tract. Co-infection with SARS-CoV-2 and LEV-8 or EV-A71 also reduced the severity of clinical manifestations of the SARS-CoV-2 infection in the animals. Additionally, the histological data illustrated that co-infection with strain LEV8 of coxsackievirus A7 decreased the level of pathological changes induced by SARS-CoV-2 in the lungs. Research into the chemokine/cytokine profile demonstrated that the studied enteroviruses efficiently triggered this part of the antiviral immune response, which is associated with the significant inhibition of SARS-CoV-2 infection. These results demonstrate that there is significant viral interference between the studied strain LEV-8 of coxsackievirus A7 or enterovirus A71 and SARS-CoV-2 in vitro and in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Research Center of Virology and Biotechnology "Vector", Koltsovo 630559, Novosibirsk Region, Russia.
ORCID-Profile: Victor A Svyatchenko, Stanislav S Legostaev, Elena V Protopopova, Vladimir V Omigov, Oleg S Taranov, Vladimir A Ternovoi, Alexander P Agafonov, Valery B Loktev
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Svyatchenko, V. A., Legostaev, S. S., Lutkovskiy, R. Y., Protopopova, E. V., Ponomareva, E. P., Omigov, V. V., Taranov, O. S., Ternovoi, V. A., Agafonov, A. P., & Loktev, V. B. (2024). Coxsackievirus A7 and Enterovirus A71 Significantly Reduce SARS-CoV-2 Infection in Cell and Animal Models. Viruses. https://doi.org/10.3390/v16060909
Vancouver
Svyatchenko VA, Legostaev SS, Lutkovskiy RY, Protopopova EV, Ponomareva EP, Omigov VV, et al. Coxsackievirus A7 and Enterovirus A71 Significantly Reduce SARS-CoV-2 Infection in Cell and Animal Models. Viruses. 2024. doi:10.3390/v16060909
BibTeX
@article{Svyatchenko2024,
author = {Svyatchenko, Victor A and Legostaev, Stanislav S and Lutkovskiy, Roman Y and Protopopova, Elena V and Ponomareva, Eugenia P and Omigov, Vladimir V and Taranov, Oleg S and Ternovoi, Vladimir A and Agafonov, Alexander P and Loktev, Valery B},
title = {Coxsackievirus A7 and Enterovirus A71 Significantly Reduce SARS-CoV-2 Infection in Cell and Animal Models},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16060909}
}
EUVIMED